Strategies to manage hepatitis C virus infection disease burden—Volume 4

D. S. Chen; W. Hamoudi; B. Mustapha; J. Layden; A. Nersesov; T. Reic; V. Garcia; C. Rios; L. Mateva; O. Njoya; S. A. Al-Busafi; M. K. Abdelmageed; M. Abdulla; D. Adda; O. Akin; A. Al Baqali; N. Al Dweik; K. Al Ejji; I. Al ghazzawi; S. Al Kaabi; K. Al Naamani; J. Al Qamish; M. Al Sadadi; J. Al Salman; M. AlBadri; H. E. Al-Romaihi; W. Ampofo; K. Antonov; C. Anyaike; F. Arome; A. Bane; S. Blach; M. M. Borodo; S. M. Brandon; B. Bright; M. T. Butt; I. Cardenas; H. L.Y. Chan; C. J. Chen; P. J. Chen; R. N. Chien; W. L. Chuang; D. Cuellar; M. Derbala; A. A. Elbardiny; C. Estes; E. Farag; J. Fung; I. Gamkrelidze; J. Genov; Z. Ghandour; M. Ghuloom; B. Gomez; J. Gunter; J. Habeeb; O. Hajelssedig; S. M. Himatt; I. Hrstic; C. C. Hu; C. F. Huang; Y. T. Hui; R. Jahis; D. Jelev; A. K. John; K. S. Kaliaskarova; Y. Kamel; J. H. Kao; J. Khamis; H. Khattabi; I. Khoudri; A. Konysbekova; I. Kotzev; M. S. Lai; W. C. Lao; M. H. Lee; O. Lesi; M. Li; A. Lo; C. K. Loo; B. Lukšić; A. Maaroufi; A. O. Malu; R. Mitova; R. Mohamed; M. Morović; K. Murphy; H. Nde; E. Ngige; R. Njouom; D. Nonković; S. Obekpa; S. Oguche; E. E. Okolo; O. Omede; C. Omuemu; P. Ondoa; O. Opare-Sem; S. Owusu-Ofori; R. O. Phillips; Y. N. Prokopenko; H. Razavi; D. Razavi-Shearer; K. Razavi-Shearer; B. Redae; T. Rinke de Wit; S. Robbins; L. R. Roberts; S. J. Sanad; M. Sharma; M. Simonova; T. H. Su; K. Sultan; S. S. Tan; K. Tchernev; O. T.Y. Tsang; S. Tsang; C. Tzeuton; S. Ugoeze; B. Uzochukwu; R. Vi; A. Vince; H. U. Wani; V. W.S. Wong; A. Workneh; R. Yacoub; K. I. Yesmembetov; M. Youbi; M. F. Yuen; J. D. Schmelzer

doi:10.1111/jvh.12759

Strategies to manage hepatitis C virus infection disease burden—Volume 4

D. S. Chen, W. Hamoudi, B. Mustapha, J. Layden, A. Nersesov, T. Reic, V. Garcia, C. Rios, L. Mateva, O. Njoya, S. A. Al-Busafi, M. K. Abdelmageed, M. Abdulla, D. Adda, O. Akin, A. Al Baqali, N. Al Dweik, K. Al Ejji, I. Al ghazzawi, S. Al KaabiK. Al Naamani, J. Al Qamish, M. Al Sadadi, J. Al Salman, M. AlBadri, H. E. Al-Romaihi, W. Ampofo, K. Antonov, C. Anyaike, F. Arome, A. Bane, S. Blach^*, M. M. Borodo, S. M. Brandon, B. Bright, M. T. Butt, I. Cardenas, H. L.Y. Chan, C. J. Chen, P. J. Chen, R. N. Chien, W. L. Chuang, D. Cuellar, M. Derbala, A. A. Elbardiny, C. Estes, E. Farag, J. Fung, I. Gamkrelidze, J. Genov, Z. Ghandour, M. Ghuloom, B. Gomez, J. Gunter, J. Habeeb, O. Hajelssedig, S. M. Himatt, I. Hrstic, C. C. Hu, C. F. Huang, Y. T. Hui, R. Jahis, D. Jelev, A. K. John, K. S. Kaliaskarova, Y. Kamel, J. H. Kao, J. Khamis, H. Khattabi, I. Khoudri, A. Konysbekova, I. Kotzev, M. S. Lai, W. C. Lao, M. H. Lee, O. Lesi, M. Li, A. Lo, C. K. Loo, B. Lukšić, A. Maaroufi, A. O. Malu, R. Mitova, R. Mohamed, M. Morović, K. Murphy, H. Nde, E. Ngige, R. Njouom, D. Nonković, S. Obekpa, S. Oguche, E. E. Okolo, O. Omede, C. Omuemu, P. Ondoa, O. Opare-Sem, S. Owusu-Ofori, R. O. Phillips, Y. N. Prokopenko, H. Razavi, D. Razavi-Shearer, K. Razavi-Shearer, B. Redae, T. Rinke de Wit, S. Robbins, L. R. Roberts, S. J. Sanad, M. Sharma, M. Simonova, T. H. Su, K. Sultan, S. S. Tan, K. Tchernev, O. T.Y. Tsang, S. Tsang, C. Tzeuton, S. Ugoeze, B. Uzochukwu, R. Vi, A. Vince, H. U. Wani, V. W.S. Wong, A. Workneh, R. Yacoub, K. I. Yesmembetov, M. Youbi, M. F. Yuen, J. D. Schmelzer

^*Corresponding author for this work

Medicine

Research output: Contribution to journal › Article › peer-review

17 Citations (Scopus)

Abstract

The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets—“WHO Targets” (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.

Original language	English
Pages (from-to)	44-63
Number of pages	20
Journal	Journal of Viral Hepatitis
Volume	24
DOIs	https://doi.org/10.1111/jvh.12759
Publication status	Published - Oct 2017

Keywords

diagnosis
disease burden
elimination
epidemiology
hepatitis C
hepatitis C virus
incidence
mortality
prevalence
scenarios
strategy
treatment

ASJC Scopus subject areas

Hepatology
Infectious Diseases
Virology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/jvh.12759

Cite this

Chen, D. S., Hamoudi, W., Mustapha, B., Layden, J., Nersesov, A., Reic, T., Garcia, V., Rios, C., Mateva, L., Njoya, O., Al-Busafi, S. A., Abdelmageed, M. K., Abdulla, M., Adda, D., Akin, O., Al Baqali, A., Al Dweik, N., Al Ejji, K., Al ghazzawi, I., ... Schmelzer, J. D. (2017). Strategies to manage hepatitis C virus infection disease burden—Volume 4. Journal of Viral Hepatitis, 24, 44-63. https://doi.org/10.1111/jvh.12759

Chen, DS, Hamoudi, W, Mustapha, B, Layden, J, Nersesov, A, Reic, T, Garcia, V, Rios, C, Mateva, L, Njoya, O, Al-Busafi, SA, Abdelmageed, MK, Abdulla, M, Adda, D, Akin, O, Al Baqali, A, Al Dweik, N, Al Ejji, K, Al ghazzawi, I, Al Kaabi, S, Al Naamani, K, Al Qamish, J, Al Sadadi, M, Al Salman, J, AlBadri, M, Al-Romaihi, HE, Ampofo, W, Antonov, K, Anyaike, C, Arome, F, Bane, A, Blach, S, Borodo, MM, Brandon, SM, Bright, B, Butt, MT, Cardenas, I, Chan, HLY, Chen, CJ, Chen, PJ, Chien, RN, Chuang, WL, Cuellar, D, Derbala, M, Elbardiny, AA, Estes, C, Farag, E, Fung, J, Gamkrelidze, I, Genov, J, Ghandour, Z, Ghuloom, M, Gomez, B, Gunter, J, Habeeb, J, Hajelssedig, O, Himatt, SM, Hrstic, I, Hu, CC, Huang, CF, Hui, YT, Jahis, R, Jelev, D, John, AK, Kaliaskarova, KS, Kamel, Y, Kao, JH, Khamis, J, Khattabi, H, Khoudri, I, Konysbekova, A, Kotzev, I, Lai, MS, Lao, WC, Lee, MH, Lesi, O, Li, M, Lo, A, Loo, CK, Lukšić, B, Maaroufi, A, Malu, AO, Mitova, R, Mohamed, R, Morović, M, Murphy, K, Nde, H, Ngige, E, Njouom, R, Nonković, D, Obekpa, S, Oguche, S, Okolo, EE, Omede, O, Omuemu, C, Ondoa, P, Opare-Sem, O, Owusu-Ofori, S, Phillips, RO, Prokopenko, YN, Razavi, H, Razavi-Shearer, D, Razavi-Shearer, K, Redae, B, Rinke de Wit, T, Robbins, S, Roberts, LR, Sanad, SJ, Sharma, M, Simonova, M, Su, TH, Sultan, K, Tan, SS, Tchernev, K, Tsang, OTY, Tsang, S, Tzeuton, C, Ugoeze, S, Uzochukwu, B, Vi, R, Vince, A, Wani, HU, Wong, VWS, Workneh, A, Yacoub, R, Yesmembetov, KI, Youbi, M, Yuen, MF & Schmelzer, JD 2017, 'Strategies to manage hepatitis C virus infection disease burden—Volume 4', Journal of Viral Hepatitis, vol. 24, pp. 44-63. https://doi.org/10.1111/jvh.12759

@article{bf34f2f7731a4c92a0ee4730cadb898a,

title = "Strategies to manage hepatitis C virus infection disease burden—Volume 4",

abstract = "The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets—“WHO Targets” (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.",

keywords = "diagnosis, disease burden, elimination, epidemiology, hepatitis C, hepatitis C virus, incidence, mortality, prevalence, scenarios, strategy, treatment",

author = "Chen, {D. S.} and W. Hamoudi and B. Mustapha and J. Layden and A. Nersesov and T. Reic and V. Garcia and C. Rios and L. Mateva and O. Njoya and Al-Busafi, {S. A.} and Abdelmageed, {M. K.} and M. Abdulla and D. Adda and O. Akin and {Al Baqali}, A. and {Al Dweik}, N. and {Al Ejji}, K. and {Al ghazzawi}, I. and {Al Kaabi}, S. and {Al Naamani}, K. and {Al Qamish}, J. and {Al Sadadi}, M. and {Al Salman}, J. and M. AlBadri and Al-Romaihi, {H. E.} and W. Ampofo and K. Antonov and C. Anyaike and F. Arome and A. Bane and S. Blach and Borodo, {M. M.} and Brandon, {S. M.} and B. Bright and Butt, {M. T.} and I. Cardenas and Chan, {H. L.Y.} and Chen, {C. J.} and Chen, {P. J.} and Chien, {R. N.} and Chuang, {W. L.} and D. Cuellar and M. Derbala and Elbardiny, {A. A.} and C. Estes and E. Farag and J. Fung and I. Gamkrelidze and J. Genov and Z. Ghandour and M. Ghuloom and B. Gomez and J. Gunter and J. Habeeb and O. Hajelssedig and Himatt, {S. M.} and I. Hrstic and Hu, {C. C.} and Huang, {C. F.} and Hui, {Y. T.} and R. Jahis and D. Jelev and John, {A. K.} and Kaliaskarova, {K. S.} and Y. Kamel and Kao, {J. H.} and J. Khamis and H. Khattabi and I. Khoudri and A. Konysbekova and I. Kotzev and Lai, {M. S.} and Lao, {W. C.} and Lee, {M. H.} and O. Lesi and M. Li and A. Lo and Loo, {C. K.} and B. Luk{\v s}i{\'c} and A. Maaroufi and Malu, {A. O.} and R. Mitova and R. Mohamed and M. Morovi{\'c} and K. Murphy and H. Nde and E. Ngige and R. Njouom and D. Nonkovi{\'c} and S. Obekpa and S. Oguche and Okolo, {E. E.} and O. Omede and C. Omuemu and P. Ondoa and O. Opare-Sem and S. Owusu-Ofori and Phillips, {R. O.} and Prokopenko, {Y. N.} and H. Razavi and D. Razavi-Shearer and K. Razavi-Shearer and B. Redae and {Rinke de Wit}, T. and S. Robbins and Roberts, {L. R.} and Sanad, {S. J.} and M. Sharma and M. Simonova and Su, {T. H.} and K. Sultan and Tan, {S. S.} and K. Tchernev and Tsang, {O. T.Y.} and S. Tsang and C. Tzeuton and S. Ugoeze and B. Uzochukwu and R. Vi and A. Vince and Wani, {H. U.} and Wong, {V. W.S.} and A. Workneh and R. Yacoub and Yesmembetov, {K. I.} and M. Youbi and Yuen, {M. F.} and Schmelzer, {J. D.}",

note = "Publisher Copyright: {\textcopyright} 2017 The Authors Journal of Viral Hepatitis Published by John Wiley & Sons Ltd.",

year = "2017",

month = oct,

doi = "10.1111/jvh.12759",

language = "English",

volume = "24",

pages = "44--63",

journal = "Journal of Viral Hepatitis",

issn = "1352-0504",

publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Strategies to manage hepatitis C virus infection disease burden—Volume 4

AU - Chen, D. S.

AU - Hamoudi, W.

AU - Mustapha, B.

AU - Layden, J.

AU - Nersesov, A.

AU - Reic, T.

AU - Garcia, V.

AU - Rios, C.

AU - Mateva, L.

AU - Njoya, O.

AU - Al-Busafi, S. A.

AU - Abdelmageed, M. K.

AU - Abdulla, M.

AU - Adda, D.

AU - Akin, O.

AU - Al Baqali, A.

AU - Al Dweik, N.

AU - Al Ejji, K.

AU - Al ghazzawi, I.

AU - Al Kaabi, S.

AU - Al Naamani, K.

AU - Al Qamish, J.

AU - Al Sadadi, M.

AU - Al Salman, J.

AU - AlBadri, M.

AU - Al-Romaihi, H. E.

AU - Ampofo, W.

AU - Antonov, K.

AU - Anyaike, C.

AU - Arome, F.

AU - Bane, A.

AU - Blach, S.

AU - Borodo, M. M.

AU - Brandon, S. M.

AU - Bright, B.

AU - Butt, M. T.

AU - Cardenas, I.

AU - Chan, H. L.Y.

AU - Chen, C. J.

AU - Chen, P. J.

AU - Chien, R. N.

AU - Chuang, W. L.

AU - Cuellar, D.

AU - Derbala, M.

AU - Elbardiny, A. A.

AU - Estes, C.

AU - Farag, E.

AU - Fung, J.

AU - Gamkrelidze, I.

AU - Genov, J.

AU - Ghandour, Z.

AU - Ghuloom, M.

AU - Gomez, B.

AU - Gunter, J.

AU - Habeeb, J.

AU - Hajelssedig, O.

AU - Himatt, S. M.

AU - Hrstic, I.

AU - Hu, C. C.

AU - Huang, C. F.

AU - Hui, Y. T.

AU - Jahis, R.

AU - Jelev, D.

AU - John, A. K.

AU - Kaliaskarova, K. S.

AU - Kamel, Y.

AU - Kao, J. H.

AU - Khamis, J.

AU - Khattabi, H.

AU - Khoudri, I.

AU - Konysbekova, A.

AU - Kotzev, I.

AU - Lai, M. S.

AU - Lao, W. C.

AU - Lee, M. H.

AU - Lesi, O.

AU - Li, M.

AU - Lo, A.

AU - Loo, C. K.

AU - Lukšić, B.

AU - Maaroufi, A.

AU - Malu, A. O.

AU - Mitova, R.

AU - Mohamed, R.

AU - Morović, M.

AU - Murphy, K.

AU - Nde, H.

AU - Ngige, E.

AU - Njouom, R.

AU - Nonković, D.

AU - Obekpa, S.

AU - Oguche, S.

AU - Okolo, E. E.

AU - Omede, O.

AU - Omuemu, C.

AU - Ondoa, P.

AU - Opare-Sem, O.

AU - Owusu-Ofori, S.

AU - Phillips, R. O.

AU - Prokopenko, Y. N.

AU - Razavi, H.

AU - Razavi-Shearer, D.

AU - Razavi-Shearer, K.

AU - Redae, B.

AU - Rinke de Wit, T.

AU - Robbins, S.

AU - Roberts, L. R.

AU - Sanad, S. J.

AU - Sharma, M.

AU - Simonova, M.

AU - Su, T. H.

AU - Sultan, K.

AU - Tan, S. S.

AU - Tchernev, K.

AU - Tsang, O. T.Y.

AU - Tsang, S.

AU - Tzeuton, C.

AU - Ugoeze, S.

AU - Uzochukwu, B.

AU - Vi, R.

AU - Vince, A.

AU - Wani, H. U.

AU - Wong, V. W.S.

AU - Workneh, A.

AU - Yacoub, R.

AU - Yesmembetov, K. I.

AU - Youbi, M.

AU - Yuen, M. F.

AU - Schmelzer, J. D.

PY - 2017/10

Y1 - 2017/10

N2 - The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets—“WHO Targets” (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.

AB - The hepatitis C virus (HCV) epidemic was forecasted through 2030 for 17 countries in Africa, Asia, Europe, Latin America and the Middle East, and interventions for achieving the Global Health Sector Strategy on viral hepatitis targets—“WHO Targets” (65% reduction in HCV-related deaths, 90% reduction in new infections and 90% of infections diagnosed by 2030) were considered. Scaling up treatment and diagnosis rates over time would be required to achieve these targets in all but one country, even with the introduction of high SVR therapies. The scenarios developed to achieve the WHO Targets in all countries studied assumed the implementation of national policies to prevent new infections and to diagnose current infections through screening.

KW - diagnosis

KW - disease burden

KW - elimination

KW - epidemiology

KW - hepatitis C

KW - hepatitis C virus

KW - incidence

KW - mortality

KW - prevalence

KW - scenarios

KW - strategy

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85032900250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032900250&partnerID=8YFLogxK

U2 - 10.1111/jvh.12759

DO - 10.1111/jvh.12759

M3 - Article

C2 - 29105286

AN - SCOPUS:85032900250

SN - 1352-0504

VL - 24

SP - 44

EP - 63

JO - Journal of Viral Hepatitis

JF - Journal of Viral Hepatitis

ER -

Strategies to manage hepatitis C virus infection disease burden—Volume 4

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this